These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39159680)

  • 1. The mitotic rate as a prognostic biomarker after preoperative radiotherapy for high-grade limb/trunk soft tissue sarcoma.
    Ouyang Z; Wang T; Brown J; Orosz Z; Trent S; Cosker T; Branford White H; Whitwell D; Guo X; Leonard Maxime Gibbons C
    Radiother Oncol; 2024 Nov; 200():110482. PubMed ID: 39159680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
    Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
    Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].
    Lehnhardt M; Hirche C; Daigeler A; Goertz O; Ring A; Hirsch T; Drücke D; Hauser J; Steinau HU
    Chirurg; 2012 Feb; 83(2):143-52. PubMed ID: 21695557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.
    Wang J; Song Y; Liu X; Jin J; Wang W; Yu Z; Liu Y; Li N; Fang H; Ren H; Tang Y; Tang Y; Chen B; Lu N; Qi S; Wang S; Li Y
    Cancer Med; 2019 Mar; 8(3):902-909. PubMed ID: 30740916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score.
    Schaefer IM; Hornick JL; Barysauskas CM; Raut CP; Patel SA; Royce TJ; Fletcher CDM; Baldini EH
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):375-383. PubMed ID: 28463157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
    Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
    Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
    Szkandera J; Pichler M; Liegl-Atzwanger B; Absenger G; Stotz M; Ploner F; Stojakovic T; Samonigg H; Eberhard K; Leithner A; Gerger A
    J Surg Oncol; 2014 Feb; 109(2):139-44. PubMed ID: 24122271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose preoperative radiation, resection, and reduced-field postoperative radiation for soft tissue sarcomas.
    Konieczkowski DJ; Goldberg SI; Raskin KA; Lozano-Calderon S; Mullen JT; Chen YL; DeLaney TF
    J Surg Oncol; 2021 Sep; 124(3):400-410. PubMed ID: 33866554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.
    Sekimizu M; Ogura K; Yasunaga H; Matsui H; Tanaka S; Inagaki K; Kawai A
    BMC Cancer; 2019 Jul; 19(1):657. PubMed ID: 31272407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.
    Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
    Medicine (Baltimore); 2015 Dec; 94(51):e2319. PubMed ID: 26705220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in primary soft tissue sarcoma of the extremities and trunk.
    Peiper M; Zurakowski D; Zornig C
    Langenbecks Arch Chir; 1997; 382(4):203-8. PubMed ID: 9396000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
    Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
    Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface.
    Baldini EH; Lapidus MR; Wang Q; Manola J; Orgill DP; Pomahac B; Marcus KJ; Bertagnolli MM; Devlin PM; George S; Abraham J; Ferrone ML; Ready JE; Raut CP
    Ann Surg Oncol; 2013 May; 20(5):1494-9. PubMed ID: 23242820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.
    Gannon NP; Stemm MH; King DM; Bedi M
    J Cancer Res Clin Oncol; 2019 May; 145(5):1321-1330. PubMed ID: 30847552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.
    Que Y; Jiang F; Liu L; Li Y; Chen Y; Qiu H; Zhou Z; Zhang X
    Medicine (Baltimore); 2015 May; 94(18):e844. PubMed ID: 25950696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Rate and Outcomes in Locally Recurrent Extremity and Truncal Soft Tissue Sarcoma.
    Li GZ; Seier K; Qin LX; Brennan M; Morris CD; Crago AM; Singer S
    JAMA Netw Open; 2024 Sep; 7(9):e2431530. PubMed ID: 39230901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.
    Traweek RS; Lyu HG; Witt RG; Snyder RA; Nassif EF; Krijgh DD; Smith JM; Tilney GS; Feng C; Chiang YJ; Torres KE; Roubaud MJ; Scally CP; Hunt KK; Keung EZ; Mericli AF; Roland CL
    Ann Surg Oncol; 2024 Jun; 31(6):4138-4147. PubMed ID: 38396039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.